Lakewood-Amedex Biotherapeutics Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.65 | — | — | Miss |
| Q22026 FY2026 | $0.65 | $-2.75 | -523.1% | Miss |
| Q12026 FY2026 | — | $-0.20 | — | Miss |
Back to LABT overview · LABT holders · LABT KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.